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The following review summarizes two important articles on
heart failure and cardiomyopathy that were published in the
American Journal of Cardiology two decades apart. Both
articles are extraordinary in their link to the more modern
era of cardiology, and specifically to the area of heart failure.
Heart Failure from the Point of
View of Quantitative Anatomy
by A. J. Linzbach (1)
SUMMARY
1. All normal human hearts have essentially the same number
of myocardial fibers and myocardial nuclei. During physiologic
growth the number of myocardial fibers remains constant; the
fibers enlarge, but their length-to-width ratio remains constant
(harmonic growth). The number of capillaries increases with
growth, with one capillary per four fibers in the infant and one
capillary per fiber in the adult. However, the width of the spaces
of the capillary net is essentially the same for all age groups. The
number of fibers and nuclei is roughly the same for the right
ventricle as the left; the left ventricle is heavier than the right
because its fibers are thicker. There are fewer layers of fibers in the
right ventricle than in the left. It follows from this that the inner
surface area of the right ventricle must be greater than for the left.
2. The average weight of the normal heart in man is about
300 gm. Through athletic exertion it can attain a weight of
500 gm. This increase is due to an extension of physiologic
growth, with the fibers increasing in length and width but not
increasing in number. The growth results in a larger than
normal mobilizable blood volume.
3. As a result of pathologic demands for increased heart work
as, for example, in hypertension, the “critical” heart weight of
500 gm. is exceeded. Increases in heart weight above the
“critical” level are due to increase in the number of fibers with
little further thickening. There is also an increase in capillaries,
with the ratio of one capillary per fiber maintained. The
coronary insufficiency than occurs with advanced hypertrophy is
not principally due to a failure of capillary supply but to the fact
that with hypertrophy the growth of the coronary arteries and
coronary ostia is retarded and atherosclerotic lesions of the
coronary system become more frequent.
4. As a result of the coronary insufficiency a dilatation takes
place. However, the Z-band to Z-band distance (i.e., the length
of sarcomeres) of myocardial fibers in dilated hearts is the same
as for normal hearts. In addition to longitudinal growth of the
muscle fibers in dilatation there are also structural alterations in
the myocardium with rearrangements of the architectural rela-
tionship among the muscle fibers. Therefore, dilatation as
encountered in man is not characterized by overstretched fibers.
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INTRODUCTION
In this edition of the Journal, we release the second in a series
of reviews of influential articles that have been previously
published in ACC journals, including the American Journal of
Cardiology (from 1958 to 1982), and JACC (from 1983 to the
present). The publication of these articles is only one aspect of
the ACC’s 50th anniversary commemoration, which highlights
50 years of leadership in cardiovascular care and education. The
articles are intended to encourage reflection on the remarkable
progress made in cardiovascular medicine over time, as well as
to acknowledge the amazing prescience of some early investi-
gators in anticipating and, in many cases, later guiding devel-
opments in their field.
The working group responsible for selecting these articles and
asking reviewers to write editorials solicited suggestions from
the ACC’s clinical committees and individual members.
The group achieved consensus fairly easily, including whom the
group should ask to prepare the accompanying editorials. We
initially drew up a list of 14 general areas to cover in this series,
but later found that there are several major areas of modern
cardiology, prominently molecular cardiology in which the truly
landmark articles have, alas, not yet been published in JACC.
Therefore, the working group decided not to categorize by
subject, but instead, to concentrate on the most important
articles.
The working group, a task force of the Subcommittee for the
Commemoration of the ACC 50th Anniversary, owes a great
deal to Ms. May A. Roustom and the efficient and tireless staff
at Heart House for facilitating this project. We also wish to
thank all who suggested articles and, most important, the
authors who prepared reviews for their willingness to contribute
their time and wisdom.
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This is true of dilatation whether due to coronary sclerosis,
myocarditis or excessive hypertrophy. It is called “structural
dilatation” as opposed to the “functional dilatation” of the
acutely overloaded heart. There is an increased residual ventric-
ular volume in the dilated heart, but it is not mobilizable.
5. Structural dilatation is the morphologic substrate of the
decompensated heart. The cross section area of muscle capable of
contracting is too small for the increased volume of the ventricle.
Cardiac insufficiency results, not from overstretching of the fibers
or inadequate oxygen consumption per fiber length in the
Starling sense, but for strictly mechanical reasons. The unit
muscle weight may produce a normal amount of energy liberated
on contraction but it is no longer adequate to expel a normal
stroke volume from a ventricle of these dimensions. In other
words, the essence of myocardial failure is the discrepancy
between the amount of energy necessary to expel a stroke volume
and the amount of energy available. In these studies it has been
shown that in most clinical cardiac disorders with heart failure
the discrepancy can be adduced from changes in the quantitative
morphology of the heart.
Originally published in The American Journal of Cardiology, March 1960
Review
It is remarkable that for more than 100 years dispute has
persisted and continues to occupy the editorial pages of
scholarly journals regarding the fundamental mechanism of
heart failure. Linzbach points out in his classic 1960 article
“Heart failure from the point of view of quantitative
anatomy” that at the turn of the century clinicians champi-
oned a morphologic point of view regarding hypertrophy
and heart failure, whereas pathologists defended a primary
functional abnormality (1). Although a functional basis for
heart failure has gradually won the hearts and minds of
investigators in recent times, there is now a growing
recognition that left ventricular remodeling and structural
problems related to remodeling may be the core lesion of
chronic heart failure, with functional abnormalities being
perhaps more of a secondary phenomenon (2).
It was Linzbach’s belief that the pathophysiologic abnor-
malities of the heart, including heart failure, could only be
understood when quantitative structural relations of this
organ were known. Measurable changes in the size and
shape of the diseased heart were an essential requirement. In
Linzbach’s 1960 paper he points out that in both normal
and abnormal hearts, the average distance between Z bands,
which is the length of the sarcomeres, was in all cases 1.4 m.
This important finding, that the length of the sarcomeres is
not altered by hypertrophy or pathologic dilatation, was a
landmark observation. He also pointed out that the sarco-
mere length was virtually the same for a wide variety of
mammals, suggesting that this feature was highly conserved
throughout evolution. Experiments conducted by Linzbach
and his group led them to estimate that normal ventricular
filling involved a change of sarcomere length from 1.4–1.5
m to 2 m. He pointed out that the maximum sarcomere
lengthening still compatible with normal heart function is a
little beyond 2 m. This extraordinarily important observa-
tion meant that stretching of the muscle fibers to adapt to
heart function is highly limited.
Linzbach’s laboratory had previously demonstrated that
all normal human hearts have essentially the same number
of myocytes and nuclei (3). Even though the right ventricle
is about half as heavy as the left ventricle, it has essentially
the same number of cells or myocytes. The cells of the right
ventricle were demonstrated by him and others to be smaller
than those of the left ventricle, and were arranged somewhat
differently. The paper goes on to demonstrate that during
normal postnatal growth of the heart, the cardiac myocytes
become wider and longer but maintain a fixed length to
width ratio. This concept is most important in the context
of today’s understanding regarding morphometric changes
that occur in heart failure. Gerdes and colleagues have
demonstrated that an alteration of the length-width ratio is
one of the most consistent changes that occurs during left
ventricular remodeling (4). The largest myocytes observed
by Linzbach and colleagues were in patients with heart
failure, and this has been confirmed by Gerdes and col-
leagues using more modern techniques of cell isolation (5).
Most importantly, Linzbach points out that as physio-
logic or pathologic hypertrophy occurs, the increase in the
weight of the heart is not due to an increase in the number
of cardiac myocytes, but is rather due to the cardiac
myocytes becoming thicker and longer. There is basically an
extension of the physiologic growth process of each cell.
Linzbach made the distinction between physiologic hyper-
trophy and pathologic hypertrophy based on the weight of
the heart. He considered 500 grams to be the critical heart
weight beyond which pathologic hypertrophy was occur-
ring. In the paper he points out that a left ventricular weight
of 200 grams or more is also consistent with pathologic
hypertrophy. Without the advantage of modern cell isola-
tion techniques, Linzbach conceded that there may be an
increase in the number of cardiac myocytes and cardiac
myocyte nuclei in concentric pressure hypertrophy. Today
we recognize that indeed there may be some post-neonatal
myocardial cell hyperplasia, and it may be increased in the
failing heart (6). In general, most experts continue to believe
that cardiac myocytes, being highly differentiated cells,
uncommonly enter into cell cycle. However, they clearly do
increase in size, although this is normally not accompanied
by ploidy or an increase in the number of nuclei. Despite
nearly 40 years since the publication of the Linzbach paper,
this field remains an area of disputatious but intense study.
In the 1960 paper Linzbach goes on to describe the
anatomic basis of left ventricular dilatation. He observes
that cardiac myocytes may become stretched in diastole, but
again finds that the Z band to Z band distance appears fixed
at 1.4 m, which is the same as in the normal and undilated
hypertrophied heart. He goes on to state that the dilation of
these hearts must then involve plastic structural changes
within the myocardium, probably due to elongation of
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individual cardiac cells. He speculates that focal hypoxic
necrosis commonly occurs during dilation, causing over
stretching during isometric contraction. He recognizes that
cardiac dilation can occur without hypertrophy, and is seen
in various types of cardiomyopathy including diphtheritic
myocarditis and chronic coronary atherosclerosis. Impor-
tantly, Linzbach points out that structural dilatation of the
heart is a hallmark of decompensated heart failure. This
principle still holds today, and is the basis for the develop-
ment of innovative anti-remodeling drugs, such as matrix
metalloproteinase inhibitors. He makes the interesting
point that heart failure results not from inadequate oxygen
consumption per cardiac myocyte, but is a consequence
strictly of mechanical inefficiency. He hypothesizes that
each “unit muscle weight” in heart failure likely produces a
normal amount of energy during contraction, but that this
amount of energy is no longer adequate to expel a normal
stroke volume from a ventricle with markedly enlarged
dimensions. The large, dilated heart structurally obligates a
low ejection fraction. This concept was revisited in a recent
editorial (7).
The Natural History of Idiopathic
Dilated Cardiomyopathy
by Fuster V, Gersh BJ, Giuliani ER, Tajik AJ,
Brandenburg RO, Frye RL (8)
ABSTRACT
Between 1960 and 1973, a total of 104 patients at the Mayo
Clinic had a diagnosis of idiopathic dilated cardiomyopathy on
the basis of clinical and angiographic criteria; these patients
were followed up for 6 to 20 years. Twenty-one percent of the
patients had a history of excessive consumption of alcohol, 20
percent had had a severe influenza-like syndrome within 60
days before the appearance of cardiac manifestations and 8
percent had had rheumatic fever without involvement of cardiac
valves several years before; thus, possible etiologic risk factors of
infectious-immunologic type may be important. Eighty patients
(77 percent) had an acccelerated course to death, with two thirds
of the deaths occurring within the first 2 years. Twenty-four
patients (23 percent) survived, and 18 of them had clinical
improvement and a normal or reduced heart size. Univariate
analysis at the time of diagnosis revealed three factors that were
highly predictive (p less than 0.01) of the clinical course: age,
cardiothoracic ratio on chest roentgenography and cardiac index.
Systemic emboli occurred in 18 percent of the patients who did
not receive anticoagulant therapy and in none of those who did;
thus, anticoagulant agents should probably be prescribed unless
their use is contraindicated.
Originally published in The American Journal of Cardiology, March 1981
Review
The paper by Fuster and colleagues on the natural history of
idiopathic dilated cardiomyopathy remains a time-honored
classic (8). The study was basically a carefully performed
retrospective analysis of 104 patients studied at the Mayo
Clinic between 1960 and 1973 with a diagnosis of idio-
pathic dilated cardiomyopathy. The diagnosis was estab-
lished on the basis of rigorous clinical and angiographic
criteria. Follow-up varied from six to twenty years. Al-
though it is a retrospective study with inherent selection
bias, it provides some of the most accurate information
derived from a systematic set of observations at a single
institution on this important diagnosis. In essence, the
authors believed it was the study of the natural history of
idiopathic dilated cardiomyopathy and therefore unique. All
of the patients underwent cardiac catheterization at base-
line, and the duration of follow-up was the longest reported
to date. It is a classic example of how a carefully done
descriptive study (i.e., non-hypothesis driven) can still have
an enormous impact on a field of study.
The authors were clearly ahead of their time in suggesting
that early identification of the syndrome prior to the
development of ventricular dilation, presumably by echocar-
diography, could enable earlier and possibly more successful
therapeutic intervention. This speculation was later realized
during the organization and implementation of the SOLVD
(Studies Of Left Ventricular Dysfunction) prevention trial. We
now know that early introduction of angiotensin converting
enzyme inhibitors forestalls the onset of heart failure and
markedly reduces the need for hospitalization (9).
The important issue of systemic embolism in dilated
cardiomyopathy was addressed by Fuster et al. (8). They
noted that over half of the emboli occurred within the first
year of diagnosis, and suggested that such patients might
benefit from administration of oral anticoagulant agents.
They firmly state in the paper that their current policy is to
prescribe long term anticoagulant therapy in all patients
with idiopathic dilated cardiomyopathy unless there is a
specific contraindication. The issue of whether or not to
anticoagulate such patients still has not been completely
resolved, with strong feelings both for (10) and against (11).
Uncontrolled data would suggest that some anticoagulation
may be useful for selected patients with heart failure (12). A
large randomized controlled trial has recently been planned
and will likely be launched in the near future to better
resolve this important clinical question.
The Fuster paper points out that about two-thirds of the
patients die in the first two years after diagnosis, demon-
strating an accelerated course to death. On the other hand,
the remaining patients demonstrated subjective improve-
ment, and many went on to stabilize with even some
diminishment in heart size. The authors recognized that the
more severe the clinical and hemodynamic manifestations at
the time of diagnosis, the worse the long term prognosis.
Since then many investigators have demonstrated that high
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filling pressures and a low cardiac index are associated with
a very poor prognosis. The Mayo group recognized that
21% of the patients with idiopathic dilated cardiomyopathy
were identified as having excessive alcohol consumption
according to standard criteria. They went on to reiterate that
alcohol may be deleterious in any patient with cardiomyop-
athy, and recommend complete abstinence from alcohol.
Only three of the patients had peri-partum cardiomyopathy,
and the authors believed that a family history of idiopathic
dilated cardiomyopathy was rare, occurring in only 2 of 104
patients. More current information would suggest that
familial cardiomyopathy may be more common (13,14), but
this is clearly an area that needs additional study.
The Fuster paper ends by making suggestions for future
investigators, including the need to make prospective and
systematic observations in various populations at risk, the
need for sequential biopsies to assess the histological and
ultra-structural changes, and the necessity to develop sero-
logic identification markers for possible infectious and
immunologic processes. In fact, myocardial biopsy of pa-
tients with dilated cardiomyopathy is perhaps done less
frequently today, in part because it has seemingly little
impact on the management of the syndrome. Specific
histologic and ultra-structural changes as well as serological
identification of infectious and immunologic processes have
generally been lacking, although myocardial biopsy is still
required for the diagnosis of inflammatory myocarditis and
infiltrative cardiomyopathies. The paper remains a classic in
that it accurately portrays the natural history of idiopathic
dilated cardiomyopathy as viewed in 1981 in a manner that
very much mirrors today’s view of this common disorder.
Although treatment has improved over the years, an under-
standing of the biologic underpinnings of the syndrome
remain for future investigation.
These two papers are extraordinary in their link to the
more modern era of cardiology, and specifically to the area
of heart failure. Both of them are well worth re-reading.
What is striking is how the key observations were made,
even though the techniques are somewhat dated by today’s
standards. Nevertheless, these two papers further emphasize
that careful studies done in relatively small numbers of
patients can lead to profound and lasting mechanistic enlight-
enment, a feature usually missing from today’s mega trials.
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